Pub. Date : 2013 Sep 15
PMID : 23747282
16 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
2 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
3 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
4 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
5 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
6 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
7 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
8 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
9 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
10 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
11 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
12 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
13 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
14 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
15 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |
16 | The first assay is based on the reduction of Delta(1)-pyrroline-5-carboxylate (P5C), generated from ornithine by OAT, using human pyrroline 5-carboxylate reductase 1 (PYCR1), which results in the concomitant oxidation of NADH (nicotinamide adenine dinucleotide, reduced form) to NAD+ (nicotinamide adenine dinucleotide, oxidized form). | NAD | pyrroline-5-carboxylate reductase 1 | Homo sapiens |